APOC3 and metabolic dysfunction-associated steatotic liver disease: Overall, no significant association between the polymorphism of APOC3 gene and NAFLD risk was detected (OR=1.08, 95%CI: 0.93–1.26 for dominant model, OR=1.00, 95%CI: 0.84–1.19 for recessive model, OR=1.10, 95%CI: 0.93–1.29 for CT vs CC, OR=1.02, 95%CI: 0.84–1.25 for TT vs CC) (Figure 3, Table 2).